Category:Adaptogens
More actions
An adaptogen is a plant medicine that increases the body's nonspecific resistance to physical, biological, and emotional stress, restoring physiological homeostasis without producing a primary psychostimulant or sedative effect. The concept was formalised by the Soviet pharmacologist Nikolai Lazarev in 1947 and substantially extended by his student Israel Brekhman through the 1960s and 1970s; the operational definition requires that an adaptogenic medicine (1) increase resistance to noxious physical, chemical, or biological influences in a nonspecific way; (2) have a normalising effect that is independent of the direction of the pathological state; and (3) be innocuous and produce minimal disturbance of normal physiological function.
The contemporary adaptogen pharmacopoeia includes several historically and pharmacologically distinct groups. The Ayurvedic rasayana' group: ashwagandha (Withania somnifera), the most extensively-studied modern adaptogen with controlled-trial evidence for stress, sleep, anxiety, athletic performance, and male fertility; holy basil (Ocimum tenuiflorum, tulsi); shatavari (Asparagus racemosus); and the medhya group of cognitive rasayanas. The TCM tonic group: Asian ginseng (Panax ginseng, Ren Shen), the original named adaptogen in Brekhman's work; American ginseng (Panax quinquefolius); eleuthero (Eleutherococcus senticosus, formerly Siberian ginseng; not a true Panax); astragalus (Astragalus propinquus, Huang Qi); schisandra (Schisandra chinensis); codonopsis (Codonopsis pilosula, Dang Shen, the milder substitute for Panax in extended-course tonification); reishi (Ganoderma lucidum; a fungus rather than a plant but conventionally grouped). The northern adaptogen group: rhodiola (Rhodiola rosea), the Siberian-and-Scandinavian adaptogen popularised in Western use through the Soviet research lineage; Schisandra as above; and selected lesser-known northern plants.
The Western pharmacological framing of adaptogen action centres on the hypothalamic-pituitary-adrenal axis: many of the established adaptogens modulate the HPA response to stress through effects on glucocorticoid-receptor expression, on corticotropin-releasing hormone signalling, on serum cortisol kinetics, and on the related neurotransmitter systems. Ashwagandha's withanolide fraction has demonstrated effects on serum cortisol in controlled stress-trial protocols. Rhodiola's salidroside and rosavin appear to enhance the catecholamine and serotonin response to physical and cognitive stressors. Panax ginsenosides have multiple effects across the HPA axis and the immune system. The unifying clinical claim is that an adaptogen taken regularly over weeks or months improves the body's capacity to handle stress rather than acting acutely on a specific receptor.
The contemporary controlled-trial evidence is variable in quality but is now substantial for several of the foundational adaptogens. Ashwagandha has accumulated more than two hundred controlled trials over the past two decades; meta-analyses support modest benefit for stress, anxiety, sleep, and athletic-performance outcomes. Rhodiola has fewer but generally positive trials in stress-associated fatigue and mild-to-moderate depression. Ginseng has the longest history of clinical investigation; the evidence is fragmented across specific ginsenoside preparations and indications, with selected effects on glucose tolerance, sexual function, and fatigue.
Members indexed
Ashwagandha (Withania somnifera), holy basil (Ocimum tenuiflorum), Asian ginseng (Panax ginseng), American ginseng (Panax quinquefolius), eleuthero (Eleutherococcus senticosus), rhodiola (Rhodiola rosea), schisandra (Schisandra chinensis), astragalus (Astragalus propinquus), codonopsis (Codonopsis pilosula), shatavari (Asparagus racemosus), gotu kola (Centella asiatica), reishi (Ganoderma lucidum), cordyceps (Cordyceps sinensis and C. militaris), maca (Lepidium meyenii), suma (Pfaffia paniculata, Brazilian ginseng), and Jiaogulan (Gynostemma pentaphyllum).
Notes on scope
The boundary of this category is "plant medicine demonstrated to meet the formal adaptogen criteria or used clinically as such within its source tradition." The pure psychostimulants (the caffeine plants, ephedra in its sympathomimetic action) are not adaptogens despite their wakefulness-promoting effects, because they produce primary psychostimulant action. The pure sedatives (valerian, kava) are not adaptogens despite their nervous-system action. The cognitive-enhancer-only herbs (bacopa, gotu kola, lion's mane) overlap with the adaptogen category through the medhya rasayana classification but their primary indication is cognitive rather than stress-resistance; they are cross-listed under nervine herbs and under cognitive-circulatory categories. Cordyceps and reishi are fungi rather than plants but are conventionally grouped with the adaptogen herbs in the TCM tonic literature; the fungal-medicine pages cross-link accordingly.
About these pages
This category page is an encyclopedia article about its subject. The actual index of medicines belonging to the category is generated automatically by the wiki engine, from category-membership declarations on the individual medicine pages, and appears at the foot of the page below the references.
References
This category currently contains no pages or media.